And importantly, there's no data comparing BPC-157 to other treatments that we know work in humans, like PRP - platelet-rich plasma injections - or even just structured physical therapy
These create a feedback loop, all influenced by NAD+ levels
[12] [9] Importantly, these trials have not shown increased incidence of deep vein thrombosis (DVT), pulmonary embolism (PE), or arterial thrombotic events attributable to the medication itself
Live brighter
Duoject-B Only available under veterinary authorisation
Peptides, Compounding Pharmacies, and the FDA: What Patients Actually Need to Know in 2026 There is a tremendous amount of confusion right now around peptides like BPC-157, TB-500, and GHK-Cu